Skip to main content
SpringerLink
Log in

Epidemiology of Ductal Carcinoma In Situ

  • Chapter
  • First Online:
Ductal Carcinoma In Situ and Microinvasive/Borderline Breast Cancer

Abstract

Ductal carcinoma in situ (DCIS) is a non-obligate precursor to invasive breast cancer. With the growing use of screening imaging, the incidence of this entity is rising, but the clinical impact of finding these premalignant lesions on overall population health remains to be fully elucidated. Here, we discuss the trends in the incidence, detection, treatment, and outcomes of DCIS; along with surveying the literature regarding risk factors known to predispose to this condition.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Westbrook KC, Gallager HS. Intraductal carcinoma of the breast. A comparative study. Am J Surg. 1975;130(6):667–70.

    Article  CAS  PubMed  Google Scholar 

  2. Ross DS, Wen YH, Brogi E. Ductal carcinoma in situ: morphology-based knowledge and molecular advances. Adv Anat Pathol. 2013;20(4):205–16.

    Article  PubMed  Google Scholar 

  3. Cowell CF, Weigelt B, Sakr RA, Ng CK, Hicks J, King TA, et al. Progression from ductal carcinoma in situ to invasive breast cancer: revisited. Mol Oncol. 2013;7(5):859–69.

    Article  PubMed  Google Scholar 

  4. Welch HG, Black WC. Using autopsy series to estimate the disease “reservoir” for ductal carcinoma in situ of the breast: how much more breast cancer can we find? Ann Intern Med. 1997;127(11):1023–8.

    Article  CAS  PubMed  Google Scholar 

  5. Kerlikowske K. Epidemiology of ductal carcinoma in situ. J Natl Cancer Inst Monogr. 2010;2010(41):139–41.

    Article  PubMed  Google Scholar 

  6. Ernster VL, Ballard-Barbash R, Barlow WE, Zheng Y, Weaver DL, Cutter G, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst. 2002;94(20):1546–54.

    Article  PubMed  Google Scholar 

  7. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA: Cancer J Clin. 2014;64(1):9–29.

    Article  Google Scholar 

  8. Howlader NNA, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA. SEER cancer statistics review, 1975–2011, National Cancer Institute 2014. http://seer.cancer.gov/csr/1975_2011/.

  9. Breen N, Gentleman JF, Schiller JS. Update on mammography trends: comparisons of rates in 2000, 2005, and 2008. Cancer. 2011;117(10):2209–18.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Lynge E, Ponti A, James T, Majek O, von Euler-Chelpin M, Anttila A, et al. Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the international cancer screening network. Eur J Cancer. 2014;50(1):185–92.

    Article  PubMed  Google Scholar 

  11. Sorum R, Hofvind S, Skaane P, Haldorsen T. Trends in incidence of ductal carcinoma in situ: the effect of a population-based screening programme. Breast. 2010;19(6):499–505.

    Article  PubMed  Google Scholar 

  12. SEER. Age adjusted incidence rates. http://seer.cancer.gov/faststats/selections.php?#Output.

  13. Chagpar AB, Polk HC Jr, McMasters KM. Racial trends in mammography rates: a population-based study. Surgery. 2008;144(3):467–72.

    Article  PubMed  Google Scholar 

  14. Innos K, Horn-Ross PL. Recent trends and racial/ethnic differences in the incidence and treatment of ductal carcinoma in situ of the breast in California women. Cancer. 2003;97(4):1099–106.

    Article  PubMed  Google Scholar 

  15. Anderson WF, Devesa SS. In situ male breast carcinoma in the surveillance, epidemiology, and end results database of the national cancer institute. Cancer. 2005;104(8):1733–41.

    Article  PubMed  Google Scholar 

  16. Schootman M, Kinman E, Farria D. Rural-urban differences in ductal carcinoma in situ as a proxy for mammography use over time. J Rural Health. 2003;19(4):470–6.

    Article  PubMed  Google Scholar 

  17. Kricker A, Goumas C, Armstrong B. Ductal carcinoma in situ of the breast, a population-based study of epidemiology and pathology. Br J Cancer. 2004;90(7):1382–5.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Allred DC. Ductal carcinoma in situ: terminology, classification, and natural history. J Natl Cancer Inst Monogr. 2010;2010(41):134–8.

    Article  PubMed  Google Scholar 

  19. Li CI, Daling JR, Malone KE. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001. Cancer Epidemiol Biomarkers Prev. 2005;14(4):1008–11.

    Article  PubMed  Google Scholar 

  20. Pandya S, Mackarem G, Lee AKC. Ductal carcinoma in situ: the impact of screening on clinical presentation and pathologic features. Breast J. 1998;4(3):146–51.

    Article  Google Scholar 

  21. Reeves GK, Pirie K, Green J, Bull D, Beral V, Million Women Study C. Comparison of the effects of genetic and environmental risk factors on in situ and invasive ductal breast cancer. Int J Cancer. 2012;131(4):930–7.

    Article  CAS  PubMed  Google Scholar 

  22. Reinier KS, Vacek PM, Geller BM. Risk factors for breast carcinoma in situ versus invasive breast cancer in a prospective study of pre- and post-menopausal women. Breast Cancer Res Treat. 2007;103(3):343–8.

    Article  PubMed  Google Scholar 

  23. Claus EB, Stowe M, Carter D. Breast carcinoma in situ: risk factors and screening patterns. J Natl Cancer Inst. 2001;93(23):1811–7.

    Article  CAS  PubMed  Google Scholar 

  24. Kerlikowske K, Barclay J, Grady D, Sickles EA, Ernster V. Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer. J Natl Cancer Inst. 1997;89(1):76–82.

    Article  CAS  PubMed  Google Scholar 

  25. Trentham-Dietz A, Newcomb PA, Storer BE, Remington PL. Risk factors for carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev. 2000;9(7):697–703.

    CAS  PubMed  Google Scholar 

  26. Claus EB, Petruzella S, Matloff E, Carter D. Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ. JAMA. 2005;293(8):964–9.

    Article  CAS  PubMed  Google Scholar 

  27. Hwang ES, McLennan JL, Moore DH, Crawford BB, Esserman LJ, Ziegler JL. Ductal carcinoma in situ in BRCA mutation carriers. J Clin Oncol. 2007;25(6):642–7.

    Article  PubMed  Google Scholar 

  28. Longnecker MP, Bernstein L, Paganini-Hill A, Enger SM, Ross RK. Risk factors for in situ breast cancer. Cancer Epidemiol Biomarkers Prev. 1996;5(12):961–5.

    CAS  PubMed  Google Scholar 

  29. Phillips LS, Millikan RC, Schroeder JC, Barnholtz-Sloan JS, Levine BJ. Reproductive and hormonal risk factors for ductal carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev. 2009;18(5):1507–14.

    Article  CAS  PubMed  Google Scholar 

  30. Meeske K, Press M, Patel A, Bernstein L. Impact of reproductive factors and lactation on breast carcinoma in situ risk. Int J Cancer. 2004;110(1):102–9.

    Article  CAS  PubMed  Google Scholar 

  31. Kabat GC, Kim MY, Woods NF, Habel LA, Messina CR, Wactawski-Wende J, et al. Reproductive and menstrual factors and risk of ductal carcinoma in situ of the breast in a cohort of postmenopausal women. Cancer Causes Control. 2011;22(10):1415–24.

    Article  PubMed  Google Scholar 

  32. Claus EB, Stowe M, Carter D. Oral contraceptives and the risk of ductal breast carcinoma in situ. Breast Cancer Res Treat. 2003;81(2):129–36.

    Article  CAS  PubMed  Google Scholar 

  33. Nichols HB, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Hampton JM, Newcomb PA. Oral contraceptive use and risk of breast carcinoma in situ. Cancer Epidemiol Biomarkers Prev. 2007;16(11):2262–8.

    Article  CAS  PubMed  Google Scholar 

  34. Gapstur SM, Morrow M, Sellers TA. Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women’s Health Study. JAMA. 1999;281(22):2091–7.

    Article  CAS  PubMed  Google Scholar 

  35. Gill JK, Maskarinec G, Pagano I, Kolonel LN. The association of mammographic density with ductal carcinoma in situ of the breast: the Multiethnic Cohort. Breast Cancer Res. 2006;8(3):R30.

    Article  PubMed Central  PubMed  Google Scholar 

  36. MacKenzie TA, Titus-Ernstoff L, Vacek PM, Geller B, Weiss JE, Goodrich ME, et al. Breast density in relation to risk of ductal carcinoma in situ of the breast in women undergoing screening mammography. Cancer Causes Control. 2007;18(9):939–45.

    Article  PubMed  Google Scholar 

  37. Weiss HA, Brinton LA, Brogan D, Coates RJ, Gammon MD, Malone KE, et al. Epidemiology of in situ and invasive breast cancer in women aged under 45. Br J Cancer. 1996;73(10):1298–305.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  38. Kerlikowske K, Walker R, Miglioretti DL, Desai A, Ballard-Barbash R, Buist DS. Obesity, mammography use and accuracy, and advanced breast cancer risk. J Natl Cancer Inst. 2008;100(23):1724–33.

    Article  PubMed Central  PubMed  Google Scholar 

  39. Kabat GC, Kim M, Shikany JM, Rodgers AK, Wactawski-Wende J, Lane D, et al. Alcohol consumption and risk of ductal carcinoma in situ of the breast in a cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2010;19(8):2066–72.

    Article  CAS  PubMed  Google Scholar 

  40. Terry MB, Zhang FF, Kabat G, Britton JA, Teitelbaum SL, Neugut AI, et al. Lifetime alcohol intake and breast cancer risk. Ann Epidemiol. 2006;16(3):230–40.

    Article  PubMed  Google Scholar 

  41. Trentham-Dietz A, Nichols HB, Egan KM, Titus-Ernstoff L, Hampton JM, Newcomb PA. Cigarette smoking and risk of breast carcinoma in situ. Epidemiology. 2007;18(5):629–38.

    Article  PubMed  Google Scholar 

  42. Kabat GC, Kim M, Kakani C, Tindle H, Wactawski-Wende J, Ockene JK, et al. Cigarette smoking in relation to risk of ductal carcinoma in situ of the breast in a cohort of postmenopausal women. Am J Epidemiol. 2010;172(5):591–9.

    Article  PubMed  Google Scholar 

  43. Kabat GC, Kim M, Wactawski-Wende J, Lane D, Adams-Campbell LL, Gaudet M, et al. Recreational physical activity, anthropometric factors, and risk of ductal carcinoma in situ of the breast in a cohort of postmenopausal women. Cancer Causes Control. 2010;21(12):2173–81.

    Article  PubMed  Google Scholar 

  44. Sprague BL, Trentham-Dietz A, Newcomb PA, Titus-Ernstoff L, Hampton JM, Egan KM. Lifetime recreational and occupational physical activity and risk of in situ and invasive breast cancer. Cancer Epidemiol Biomarkers Prev. 2007;16(2):236–43.

    Article  PubMed  Google Scholar 

  45. Patel AV, Press MF, Meeske K, Calle EE, Bernstein L. Lifetime recreational exercise activity and risk of breast carcinoma in situ. Cancer. 2003;98(10):2161–9.

    Article  PubMed  Google Scholar 

  46. Ashikari R, Hajdu SI, Robbins GF. Intraductal carcinoma of the breast. (1960–1969). Cancer. 1971;28(5):1182–7.

    Article  CAS  PubMed  Google Scholar 

  47. Rauch GM, Kuerer HM, Scoggins ME, Fox PS, Benveniste AP, Park YM, et al. Clinicopathologic, mammographic, and sonographic features in 1187 patients with pure ductal carcinoma in situ of the breast by estrogen receptor status. Breast Cancer Res Treat. 2013;139(3):639–47.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  48. Barnes NL, Dimopoulos N, Williams KE, Howe M, Bundred NJ. The frequency of presentation and clinico-pathological characteristics of symptomatic versus screen detected ductal carcinoma in situ of the breast. Eur J Surg Oncol. 2014;40(3):249–54.

    Article  CAS  PubMed  Google Scholar 

  49. Skaane P. Studies comparing screen-film mammography and full-field digital mammography in breast cancer screening: updated review. Acta Radiol. 2009;50(1):3–14.

    Article  CAS  PubMed  Google Scholar 

  50. Breslin TM, Banerjee M, Gust C, Birkmeyer NJ. Trends in advanced imaging use for women undergoing breast cancer surgery. Cancer. 2013;119(6):1251–6.

    Article  PubMed  Google Scholar 

  51. Lehman CD. Magnetic resonance imaging in the evaluation of ductal carcinoma in situ. J Natl Cancer Inst Monogr. 2010;2010(41):150–1.

    Article  PubMed  Google Scholar 

  52. Menell JH, Morris EA, Dershaw DD, Abramson AF, Brogi E, Liberman L. Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J. 2005;11(6):382–90.

    Article  PubMed  Google Scholar 

  53. Kuhl CK, Schrading S, Bieling HB, Wardelmann E, Leutner CC, Koenig R, et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet. 2007;370(9586):485–92.

    Article  PubMed  Google Scholar 

  54. Pilewskie M, Kennedy C, Shappell C, Helenowski I, Scholtens D, Hansen N, et al. Effect of MRI on the management of ductal carcinoma in situ of the breast. Ann Surg Oncol. 2013;20(5):1522–9.

    Article  PubMed  Google Scholar 

  55. Itakura K, Lessing J, Sakata T, Heinzerling A, Vriens E, Wisner D, et al. The impact of preoperative magnetic resonance imaging on surgical treatment and outcomes for ductal carcinoma in situ. Clin Breast Cancer. 2011;11(1):33–8.

    Article  PubMed  Google Scholar 

  56. Kropcho LC, Steen ST, Chung AP, Sim MS, Kirsch DL, Giuliano AE. Preoperative breast MRI in the surgical treatment of ductal carcinoma in situ. Breast J. 2012;18(2):151–6.

    Article  PubMed  Google Scholar 

  57. Pilewskie M, Olcese C, Eaton A, Patil S, Morris E, Morrow M, et al. Perioperative breast MRI is not associated with lower locoregional recurrence rates in DCIS patients treated with or without radiation. Ann Surg Oncol. 2014;21(5):1552–60.

    Article  PubMed  Google Scholar 

  58. Greenberg JS, Javitt MC, Katzen J, Michael S, Holland AE. Clinical performance metrics of 3D digital breast tomosynthesis compared with 2D digital mammography for breast cancer screening in community practice. AJR Am J Roentgenol. 2014:1–7.

    Google Scholar 

  59. Fisher B, Costantino J, Redmond C, Fisher E, Margolese R, Dimitrov N, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med. 1993;328(22):1581–6.

    Article  CAS  PubMed  Google Scholar 

  60. Coleman EA, Kessler LG, Wun LM, Feuer EJ. Trends in the surgical treatment of ductal carcinoma in situ of the breast. Am J Surg. 1992;164(1):74–6.

    Article  CAS  PubMed  Google Scholar 

  61. Baxter NN, Virnig BA, Durham SB, Tuttle TM. Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst. 2004;96(6):443–8.

    Article  PubMed  Google Scholar 

  62. Tuttle TM, Jarosek S, Habermann EB, Arrington A, Abraham A, Morris TJ, et al. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol. 2009;27(9):1362–7.

    Article  PubMed  Google Scholar 

  63. Coopey SB, Tang R, Lei L, Freer PE, Kansal K, Colwell AS, et al. Increasing eligibility for nipple-sparing mastectomy. Ann Surg Oncol. 2013;20(10):3218–22.

    Article  PubMed  Google Scholar 

  64. Lyman GH, Temin S, Edge SB, Newman LA, Turner RR, Weaver DL, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American society of clinical oncology clinical practice guideline update. J Clin Oncol. 2014;32(13):1365–83.

    Article  PubMed  Google Scholar 

  65. Silverstein MJ, Poller DN, Waisman JR, Colburn WJ, Barth A, Gierson ED, et al. Prognostic classification of breast ductal carcinoma-in-situ. Lancet. 1995;345(8958):1154–7.

    Article  CAS  PubMed  Google Scholar 

  66. Hughes LL, Wang M, Page DL, Gray R, Solin LJ, Davidson NE, et al. Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the eastern cooperative oncology group. J Clin Oncol. 2009;27(32):5319–24.

    Article  PubMed Central  PubMed  Google Scholar 

  67. Yao K, Czechura T, Liederbach E, Winchester DJ, Pesce C, Shaikh A, et al. Utilization of accelerated partial breast irradiation for ductal carcinoma in situ, 2003-2011: report from the national cancer database. Ann Surg Oncol. 2014.(Epub ahead of print).

    Google Scholar 

  68. Fisher B, Dignam J, Wolmark N, Wickerham DL, Fisher ER, Mamounas E, et al. Tamoxifen in treatment of intraductal breast cancer: national surgical adjuvant breast and bowel project B-24 randomised controlled trial. Lancet. 1999;353(9169):1993–2000.

    Article  CAS  PubMed  Google Scholar 

  69. Zujewski JA, Harlan LC, Morrell DM, Stevens JL. Ductal carcinoma in situ: trends in treatment over time in the US. Breast Cancer Res Treat. 2011;127(1):251–7.

    Article  PubMed  Google Scholar 

  70. http://seer.cancer.gov/faststats/.

  71. Ernster VL, Barclay J, Kerlikowske K, Wilkie H, Ballard-Barbash R. Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. Arch Intern Med. 2000;160(7):953–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Smilow Cancer Hospital at Yale New Haven, Yale New Haven Hospital, 20 York Street, North Pavilion, First Floor, 06510, New Haven, CT, USA

    Anees B. Chagpar MD, MSc, MPH, MA, MBA, FRCS(C), FACS

  2. Department of Surgery, Yale University School of Medicine, Yale New Haven Hospital, 20 York Street, North Pavilion, First Floor, 06510, New Haven, CT, USA

    Prathima Kanumuri MD

Authors
  1. Prathima Kanumuri MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anees B. Chagpar MD, MSc, MPH, MA, MBA, FRCS(C), FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anees B. Chagpar MD, MSc, MPH, MA, MBA, FRCS(C), FACS .

Editor information

Editors and Affiliations

  1. Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor, Michigan, USA

    Lisa A. Newman

  2. Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor, Michigan, USA

    Jessica M. Bensenhaver

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Kanumuri, P., Chagpar, A. (2015). Epidemiology of Ductal Carcinoma In Situ. In: Newman, L., Bensenhaver, J. (eds) Ductal Carcinoma In Situ and Microinvasive/Borderline Breast Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2035-8_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2035-8_1

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-2034-1

  • Online ISBN: 978-1-4939-2035-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation